These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9457711)

  • 1. Acute hydrocephalus after iotrolan lumbar myelography.
    Tseng SH; Tseng WS
    Neuroradiology; 1997 Dec; 39(12):863-4. PubMed ID: 9457711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aseptic meningitis complicating iotrolan myelography.
    Nakakoshi T; Moriwaka F; Tashiro K; Nakane K; Miyasaka K
    AJNR Am J Neuroradiol; 1991; 12(1):173. PubMed ID: 1899506
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A; Jensen C; Saebye A; Rasmussen TB
    Acta Radiol; 1994 Mar; 35(2):182-5. PubMed ID: 8172748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI; Potthoff PC; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():148-52. PubMed ID: 2568783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe symptomatic aseptic chemical meningitis following myelography: the role of procalcitonin.
    Bender A; Elstner M; Paul R; Straube A
    Neurology; 2004 Oct; 63(7):1311-3. PubMed ID: 15477562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B; Albrecht A; Bingas B; Becker H; Brunke J; von Einsiedel H; Mariss G; Schmidt K; Thun F; Valavanis A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():171-5. PubMed ID: 2568789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraspinal arachnoiditis and hydrocephalus after lumbar myelography using methylglucamine iocarmate.
    Jensen TS; Hein O
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):108-12. PubMed ID: 305466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison in myelography between iodixanol 270 and 320 mgI/ml and iotrolan 300 mgI/ml: a multicentre, randomised, parallel-group, double-blind, phase III trial.
    Palmers Y; Kuhn FP; Petersen D; De Greef D
    Eur Radiol; 2002 Mar; 12(3):686-91. PubMed ID: 11870488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective comparison of iotrolan, iohexol and iopamidol for lumbar myelography.
    Lamb J; McAllister V; Nelson M; Bartlett R; Smith I; Deopugari CE
    Acta Radiol Suppl; 1986; 369():524-7. PubMed ID: 2980547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical study with iotrolan versus metrizamide in lumbar myelography.
    Inoue S; Watanabe T; Yamamura H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():161-6. PubMed ID: 2568787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse reactions and intracranial contrast medium after myelography].
    Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R
    Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Fiirgaard B; Madsen HH; Svare U; Eriksen FB; Skjødt T; Zeeberg I
    Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K; Klotz E; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions in myelography.
    Maly P; Sundgren P; Baath L; Golman K; Walday P
    Acta Radiol Suppl; 1995; 399():230-7. PubMed ID: 8610521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience of iotrolan].
    Ishikawa M; Handa H
    Nihon Geka Hokan; 1986 May; 55(3):485-9. PubMed ID: 3800545
    [No Abstract]   [Full Text] [Related]  

  • 16. Iotrolan, a nonionic dimeric contrast medium in myelography.
    Bien S; Schumacher M; Berger W; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of Iotrolan encephalopathy].
    Suga T; Goto H; Yoshioka K; Hosoya T
    No Shinkei Geka; 1996 Nov; 24(11):1051-4. PubMed ID: 8934476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iotrolan versus iopamidol for cervical myelography: a randomized double-blind trial.
    Coutinho C; McGeorge A; Macpherson P; Teasdale E
    Br J Radiol; 1988 Oct; 61(730):965-7. PubMed ID: 3056560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iotrolan versus iopamidol. A controlled double-blind study with lumbar myelography].
    Maier B; Gerber U; König M; Stetter G
    Radiologe; 1992 Aug; 32(8):393-6. PubMed ID: 1410326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iotrolan. The first dimeric non-ionic contrast medium for the subarachnoid space.
    Wenzel-Hora BI
    Acta Radiol Suppl; 1986; 369():545-8. PubMed ID: 2980554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.